Smooth Operator: Nanotextured Breast Tissue Expanders Are Associated with Lower Rates of Capsular Contracture
- PMID: 39407864
- PMCID: PMC11477145
- DOI: 10.3390/jcm13195803
Smooth Operator: Nanotextured Breast Tissue Expanders Are Associated with Lower Rates of Capsular Contracture
Abstract
Background: Continuous research on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has introduced a focus on surface texturizations and a shift towards smooth breast devices, yet outcomes comparing the complication profiles of differently textured tissue expanders (TEs) remain conflicting. The study aim was to compare the complication profile of a new nanotextured and MRI-compatible TE to micro- and macrotextured TEs and to identify possible predictors for complications. Methods: A retrospective analysis of women undergoing expander-based breast reconstruction after mastectomy between January 2016 and March 2022 was conducted. The primary endpoint was the development of capsular contracture. Possible predictors were analyzed in a mixed-effects model using the least absolute shrinkage and selection operator (LASSO). Moreover, a comparison of complications and an evaluation of predictors were carried out. Results: A total of 147 breasts, encompassing 82 nanotextured, 43 microtextured and 22 macrotextured TEs, were analyzed. Breasts with nanotextured TEs were less likely to develop capsular contracture overall (OR, 0.12; 95%CI 0.05-0.28, p < 0.001). Post-mastectomy radiotherapy (PMRT) was identified as a predictor for capsular contracture (OR, 4.67; 95%CI 1.86-11.71, p < 0.001). Breasts with nanotextured TEs showed a higher rate of seroma, but lower rates of malposition and pain. Predictors for developing postoperative complications included higher mastectomy weight (p = 0.008). Conclusions: Breasts with nanotextured TEs exhibited the lowest rate of capsular contracture compared to micro- and macrotextured TEs. Together with its MRI-compatibility and improved oncologic follow-up, the nanotextured TE seems to be a favorable device for expander-based breast reconstruction.
Keywords: BIA-ALCL; biocompatibility; breast reconstruction; capsular contracture; mastectomy; surface texturization; tissue expander.
Conflict of interest statement
YH receives financial compensation for travel, accommodation and teaching from Establishment Labs, San José, Costa Rica and pfm medical Gmbh, Cologne, Germany. All other authors have no conflicts of interest to declare.
Figures



Similar articles
-
Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy.Ann Plast Surg. 2022 May 1;88(3 Suppl 3):S288-S292. doi: 10.1097/SAP.0000000000003193. Ann Plast Surg. 2022. PMID: 35513333
-
Textured versus Smooth Tissue Expanders: A Comparison of Complications in 3526 Breast Reconstructions.Plast Reconstr Surg. 2024 Feb 1;153(2):262e-272e. doi: 10.1097/PRS.0000000000010600. Epub 2023 Apr 26. Plast Reconstr Surg. 2024. PMID: 37104467 Free PMC article.
-
A Propensity Score-Matched Comparison of Perioperative Outcomes in Prepectoral Smooth Versus Textured Tissue Expander Breast Reconstruction.Ann Plast Surg. 2023 May 1;90(5S Suppl 3):S242-S251. doi: 10.1097/SAP.0000000000003397. Ann Plast Surg. 2023. PMID: 37227405
-
Radiation Modality (Proton/Photon), Timing, and Complication Rates in Patients With Breast Cancer Receiving 2-Stages Expander/Implant Reconstruction.Pract Radiat Oncol. 2022 Nov-Dec;12(6):475-486. doi: 10.1016/j.prro.2022.05.017. Epub 2022 Jun 27. Pract Radiat Oncol. 2022. PMID: 35989216 Free PMC article. Review.
-
Reduced capsular contracture with smooth and textured breast implants following submuscular mammoplasty: systematic literature review.Future Oncol. 2021 Dec;17(36):5177-5187. doi: 10.2217/fon-2021-0510. Epub 2021 Nov 3. Future Oncol. 2021. PMID: 34730405
References
-
- Allemani C., Matsuda T., Di Carlo V., Harewood R., Matz M., Nikšić M., Bonaventure A., Valkov M., Johnson C.J., Estève J., et al. Global Surveillance of Trends in Cancer Survival 2000–14 (CONCORD-3): Analysis of Individual Records for 37,513,025 Patients Diagnosed with One of 18 Cancers from 322 Population-Based Registries in 71 Countries. Lancet. 2018;391:1023–1075. doi: 10.1016/S0140-6736(17)33326-3. - DOI - PMC - PubMed
-
- Eltahir Y., Werners L.L., Dreise M.M., Zeijlmans van Emmichoven I.A., Jansen L. Quality-of-Life Outcomes Between Mastectomy Alone and Breast Reconstruction: Comparison of Patient-Reported BREAST-Q and Other Health-Related Quality-of-Life Measures. Breast Dis. Year Book Q. 2014;25:69–70. doi: 10.1097/PRS.0000000000000041. - DOI - PubMed
-
- Dempsey K., Mathieu E., Brennan M., Snook K., Hoffman J., Campbell I., Scarlet J., Flay H., Wong A., Boyle F., et al. Patient-Reported Health-Related Quality of Life Outcomes Following Mastectomy for Breast Cancer, with Immediate, Delayed or No Breast Reconstruction: Four-Year Follow-up from a Prospective Cohort Study. Breast. 2023;71:122–131. doi: 10.1016/j.breast.2023.08.001. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources